There are 2934 resources available
6572 - CheckMate 459: A Randomized, Multi-Center Phase 3 Study of Nivolumab (NIVO) vs Sorafenib (SOR) as First-Line (1L) Treatment in Patients (pts) With Advanced Hepatocellular Carcinoma (aHCC)
Presenter: Thomas Yau
Session: Proffered Paper 1 – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Systemic treatment
Presenter: Giovanni Grignani
Session: ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment
Resources:
Slides
Webcast
Outcome of the 2019 United Nation’s high-level meeting on universal health coverage
Presenter: André Ilbawi
Session: Universal health coverage and cancer: What you and your country need to know
Resources:
Slides
Webcast
The methodology and country support for setting cancer priorities for universal health coverage
Presenter: Dario Trapani
Session: Universal health coverage and cancer: What you and your country need to know
Resources:
Slides
Webcast
Including cancer services in universal health coverage packages
Presenter: André Ilbawi
Session: Universal health coverage and cancer: What you and your country need to know
Resources:
Slides
Webcast
Proffered Paper 1 - NSCLC, metastatic - Invited Discussant 1478O and 1479O
Presenter: Lizza Hendriks
Session: Proffered Paper 1 - NSCLC, metastatic
Resources:
Slides
Webcast
Proffered Paper 1 - NSCLC, metastatic - Invited Discussant LBA79 and LBA80
Presenter: Naiyer Rizvi
Session: Proffered Paper 1 - NSCLC, metastatic
Resources:
Slides
Webcast
Bone health in cancer patients: Improving survival
Presenter: Robert Coleman
Session: ESMO-MASCC Collaborative session: Management of cancer and anticancer therapy induced side effects
Resources:
Slides
Webcast
Prevention of febrile neutropenia: The updated guidelines
Presenter: Matti Aapro
Session: ESMO-MASCC Collaborative session: Management of cancer and anticancer therapy induced side effects
Resources:
Slides
Webcast
Safe usage of immunotherapy
Presenter: Stephane Champiat
Session: ESMO-MASCC Collaborative session: Management of cancer and anticancer therapy induced side effects
Resources:
Slides
Webcast